Pay in 4 interest-free payments of $6.41 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Senolytic Peptide FOXO4-DRI Selectively Removes Senescent Cells From in vitro Expanded Human Chondrocytes Huang Y, He Y, Makarcyzk MJ, Lin H Frontiers in Bioengineering and Biotechnology (2021) This study demonstrated that FOXO4-DRI selectively removes senescent cells from human chondrocyte cultures expanded in vitro, providing direct evidence of the peptide's senolytic activity in human cells relevant to joint and cartilage aging
Effect of Incretin-Based Therapies on Blood Pressure: A Systematic Review and Meta-Analysis
What is Exenatide extended release (Bydureon BCise)
The health and safety hazards associated with the handling of peptides in a research setting
,aspect=ignore)
US$ 26.93
US$ 25.98
US$ 24.26
,aspect=ignore)
US$ 28.82
US$ 29.20
US$ 25.28
